Micap Share Discussion Threads

[Abuse team] 06/4/2006 15:38

Post removed by ADVFN

[unionhall] 06/4/2006 15:33

Fair enough - go for it but not for me.

Reason being that I was in Micap two years ago when sentiments were similar.

The real question for me is how quickly they can turn the technology into realistic revenues and they have consistently disappointed on this.

Even in this trading statement they once again say progress has been slower than hoped so they still have not got their forecasting to a realistic level.

In answer to your question - almost always when coming off the back of a graph like this one....

Anyway - hope it works out for you Mike.

Cheers.

[mikehardman] 06/4/2006 15:27

unionhall - 'a bit away yet' - indeed, maybe so, no dispute with you there.
But since when does the market wait for stuff such as profitability, comfortable cash position, etc. before starting a recovery?
There's no doubt risk persists, but down here, and after the improved tr.stmt, the risk/reward ratio has improved significantly, IMO.

[unionhall] 06/4/2006 15:08

Don't quite see it -

Approx 600k loss for the half year - they will be out of cash again in six months.

They only raised net 740k in Nov on top of approx 160k on hand at Sept year-end.

(Plus the cost of refitting the Athlone plant)


Profitability would require a tripling of second half revenue with no increase in costs. This is a bit away yet....

[mikehardman] 06/4/2006 13:27

took an hour for my buy to appear;
tick-up

[maestro.] 06/4/2006 13:07

EXCELLENT TRADING STATEMENT...BARGAIN OF THE YEAR!

[maestro.] 06/4/2006 12:51

GET IN QUICK!
Micap plc

Trading update


Micap plc ('Micap' or the 'Company') announces progress in its four business
units and a significant increase in revenue in the second half of the financial
year.


Micap is a provider of microencapsulation solutions to a range of customers in
fields such as flavour delivery, agrochemicals, healthcare and industrial
applications, using both its proprietary yeast cell technology and bespoke
methods developed by its scientific team.


The Company's patented Yeast Technology continues to generate interest in
agrochemicals. We are currently negotiating call options in two fields of
fungicidal application, with two major multinational companies. In addition the
use of natural essential oils as a pesticide is under consideration with a
potential partner.


Our Bespoke Solutions division, based in Bremerhaven, Germany, has introduced
its natural Jojoba bead product to a number of major cosmetics manufacturers.
Orders for more than a tonne of the beads have been shipped recently, and we are
expecting to see an increased take up of the product. We also have a number of
funded projects underway with companies in fields as diverse as bread-making,
steel production and sports nutrition, which we are hopeful will lead to new
product developments.


Our Production facility at Athlone, Ireland has shipped its first major order of
yeast encapsulated mustard, and has received forward orders for 8 tonnes of this
product in the next half year. This is validation of the yeast technology in
application, and we are now seeking further customers for our mustard and garlic
products.


The production contract with the major flavour company, which was mentioned in
the interim results has not yet been concluded. We are currently finalising the
specification for the second phase of the upgrade to the plant, which we will
need to carry out to service this contract, and we anticipate this will be
concluded in the near future. If it is not trading will be impacted, but we have
identified a number of alternative customers with whom we are in discussions
regarding production contracts.


The Applied Analysis division based in York, has had a good second half, and has
achieved its best ever monthly sales under Group ownership.


The lease on our former head office site at Haydock has attracted some interest,
and we are in negotiations with a potential assignee. The conclusion of this
assignment will help cash-flow significantly.


We intend to issue our preliminary announcement during the week commencing 15th
May 2006. Our revenues for the second half of the financial year have grown more
than 50% compared with the first half. This is a reflection of the new group
structure which has been put in place over the last year, and whilst progress is
not as swift as originally hoped, we continue to move closer to profitability as
each of our trading divisions grows its revenues and we maintain our strict cost
control.


Michael Norris

Chief Executive

[jessica5] 06/4/2006 12:43

RNS Number:1229B
MICAP PLC
06 April 2006




For Release 6th April 2006



Micap plc

Trading update


Micap plc ("Micap" or the "Company") announces progress in its four business
units and a significant increase in revenue in the second half of the financial
year.


Micap is a provider of microencapsulation solutions to a range of customers in
fields such as flavour delivery, agrochemicals, healthcare and industrial
applications, using both its proprietary yeast cell technology and bespoke
methods developed by its scientific team.


The Company's patented Yeast Technology continues to generate interest in
agrochemicals. We are currently negotiating call options in two fields of
fungicidal application, with two major multinational companies. In addition the
use of natural essential oils as a pesticide is under consideration with a
potential partner.


Our Bespoke Solutions division, based in Bremerhaven, Germany, has introduced
its natural Jojoba bead product to a number of major cosmetics manufacturers.
Orders for more than a tonne of the beads have been shipped recently, and we are
expecting to see an increased take up of the product. We also have a number of
funded projects underway with companies in fields as diverse as bread-making,
steel production and sports nutrition, which we are hopeful will lead to new
product developments.


Our Production facility at Athlone, Ireland has shipped its first major order of
yeast encapsulated mustard, and has received forward orders for 8 tonnes of this
product in the next half year. This is validation of the yeast technology in
application, and we are now seeking further customers for our mustard and garlic
products.


The production contract with the major flavour company, which was mentioned in
the interim results has not yet been concluded. We are currently finalising the
specification for the second phase of the upgrade to the plant, which we will
need to carry out to service this contract, and we anticipate this will be
concluded in the near future. If it is not trading will be impacted, but we have
identified a number of alternative customers with whom we are in discussions
regarding production contracts.


The Applied Analysis division based in York, has had a good second half, and has
achieved its best ever monthly sales under Group ownership.


The lease on our former head office site at Haydock has attracted some interest,
and we are in negotiations with a potential assignee. The conclusion of this
assignment will help cash-flow significantly.


We intend to issue our preliminary announcement during the week commencing 15th
May 2006. Our revenues for the second half of the financial year have grown more
than 50% compared with the first half. This is a reflection of the new group
structure which has been put in place over the last year, and whilst progress is
not as swift as originally hoped, we continue to move closer to profitability as
each of our trading divisions grows its revenues and we maintain our strict cost
control.


Michael Norris

Chief Executive

[mikehardman] 06/4/2006 12:42

long 3.94
better sentiment in that tr.stmt today than for a good while
scope for 20-bagging
gotta be worth a punt down here?

[m.t.glass] 08/2/2006 17:09

"..Evershed monitors the share price of
a large number of companies and will buy
shares in companies he likes when they
are very depressed.." (Shmag, April 2004)

"...I'm absolutely stuffed with technology at
the moment – it makes up 30% of the portfolio.
The uplift's absolutely enormous if you get the
right ones..." (MoneyWeek interview, Nov 2005)

[the bull] 08/2/2006 16:53

afraid not for now but it has to be a good sign, break even would be nice one day having been tipped these from the BPRG pyramid selling scheme

[arnoldlane] 08/2/2006 16:37

Patrick Evershed owns Micap personally!!!

For those that don't know, Patrick Evershed is the manager of New Star Select Opportunities Fund and previously the manager of Rathbones Special Situations Fund. He is a very well known small cap investor with an excellent long term track record. When he joined New Star his new fund was limited at £50m and was heavily oversubscribed.

A personal holding is a major vote of confidence. I'd have thought these should move up on this news.

al

[janus62] 08/2/2006 15:10

MICAP PLC
08 February 2006

Micap plc (the 'Company')

8 February 2006

Notifiable Interest


The Company was advised by a letter dated 12 December 2005 that following the
placing of shares of the Company in December 2005, Patrick Evershed is
interested in 2,142,860 Ordinary Shares representing 3.84% of the Company's
issued share capital of that class (based on 55,825,225 shares in issue).

[hallucigenia] 07/2/2006 14:31

have it on good authority that the 200k @4.7 was in fact a buy

JP Morgan have had stock to sell at 4.6-ish when the spread was 4.5/5.0, so you can't read much into any of the trades until they've got rid of the rest of their holding. They had 3,275,909 shares (5.87%) at the time of their last RNS, so that's a fair old overhang for something as illiquid as Micap - and represents an opportunity for anyone with a good broker.

Still, it's interesting to see a number of trades going through at substantially more than 4.6p, even though most of them are small investors getting mugged by the market.

[cee man] 02/2/2006 21:25

have it on good authority that the 200k @4.7 was in fact a buy

c

[beckaroo] 02/2/2006 08:22

Has the price gone up 5% because a director spent all of £1 on shares!!

Director's Dealing

1 February 2006

Micap plc, the provider of microencapsulation solutions, received notification
yesterday that, on 31 January 2006, Michael J Norris, Managing Director,
purchased 24,422 Convertible Shares of 25 pence each in the Company, at a price
of #1 (or 0.0041p per Convertible Share).

[unionhall] 11/1/2006 10:09

Micap News January 2006.


A New Year and a new look for Micap. This month we reveal our expansion in manufacturing capabilities with the acquisition of a spray drying plant in Ireland. In addition we also celebrate the funding for anti-malaria projects with the Liverpool School of Tropical Medicine. An increasing level of commercial activity has led to Micap saying farewell to our Newton-Le-Willows headquarters and details and locations of our new divisions can be found inside.

[m.t.glass] 22/12/2005 09:20

At the start of this thread I owned shares in another food tech company, Clover (CLR) but not for long. Both dismal performers.

[bigboony] 22/12/2005 07:31

how long before Micap goes bust? Net assets almost entirely made up of intangable assets, consistant loss maker with operational costs more than twice that of revenue....tick tock tick tock

And to think I bought into this heap at 56p this is my all time biggest loser, I think I will sell out today and pick up the pathetic 9% of my original investment rather than wait until bust!

[janus62] 22/12/2005 07:08

Interim results for the six months to 30th September 2005

HIGHLIGHTS

• Successful placing of new Ordinary shares to raise £825,000.
• Reduced loss per ordinary share of 2.0p (2004: loss 2.4p);
After tax loss of £0.59 million (2004 - loss £0.68m).
• Operating loss reduced by 17 % to £0.69 million (2004: loss
£0.83 million).
• Four distinct operating companies now within the Group
delivering a growing range of customer and revenue
oportunities.
• Significant progress in commercialisation of Micap
technologies.
• Acquisition of 100% of Micap Encapsulates Ltd.
• Programme of cost reduction across Group continues to be
implemented.

[janus62] 22/11/2005 13:14

MICAP PLC
22 November 2005



Micap Plc ('the Company')
22 November 2005
Significant Shareholder


The Company were informed by a letter dated 21 November 2005 that AXA S.A. of 25
Avenue Matignon, 75008 Paris and its Group Companies, were interested in
3,775,909 ordinary 25p shares in the share capital of the Company. These shares
are represented by a non-beneficial interest.


The identity of each registered holder of the shares to which this notice
relates, so far as is known to AXA Investment Managers UK Ltd, as at 18 November
2005, is as follows:


Name of the Number of Particulars of

Company / Fund Shares Beneficial Owners
Framlington HSBC 3,775,909 HSBC Global Custody Nominee
(UK) Limited



End.


This information is provided by RNS
The company news service from the London Stock Exchange

[arnoldlane] 21/11/2005 11:11

dan,

I'm intrigued by your comments...would you care to eloborate?

al

[kalingalinga] 19/11/2005 14:16

dan. been doing some dd have we? k

[_dan_] 18/11/2005 17:36

Their patents don't look strong!

Not a long term investment IMO

[arnoldlane] 18/11/2005 15:44

MTG,

Not too worry...it happens to the best of us! I once thought that NXT was going to be a FTSE 100 company!!!

I do feel however that Micap is very interesting. They have been forced to raise money at a pre-money valuation of £1.25m. That is totally derisory and wouldn't even happen if the company was private. This is the trouble with AIM if you float a company too soon. It has to wash its dirty laundry in public and then gets savaged for what many would see as inevitable delays.

Personally I think that previous management have been too ambitious and have spent too freely ahead of expected revenues. Now expectations are so low that any success will result in a very significant return.

Every portfolio has room for a Micap. Just not too much. If they get it right then 5-10x return is possible over a couple of years. And you can only lose 100%!

al